Although this interaction has never been described in the context of glioma, the ribosomal protein S19 (RPS19) is upregulated in breast and ovarian cancers, and its interaction with the C5a receptor 1 (C5AR1), expressed on tumor-infiltrating myeloid cells, has an immunosuppressive effect. Here, C5AR1 is linked to central nervous system cancer.